Articles related to TESTING/LABS

Blood biomarker testing offers 91.7% accuracy in detecting amyloid plaques while providing more accessible alternative to cerebrospinal fluid analysis, though confirmation via PET or CSF remains necessary for indeterminate results.

Conditions that warrant gastrointestinal pathogen panel testing include fever, visible blood in the stool, sepsis, severe abdominal pain, hospitalization, persistent diarrhea (≥ 7 days), advanced age, and immunocompromise.

“Many factors external to the thyroid gland can modulate these diverse effects, making it difficult to assess the thyroid status of patients solely on clinical grounds.”

Flow cytometric evaluation of MRD in AML demonstrates that blast phenotypes consistently show abnormalities but may evolve during treatment, emphasizing the importance of comprehensive antigen panel analysis for accurate detection.

The Flynn effect reveals a consistent increase in global IQ scores since standardized testing began, suggesting significant implications for cognitive assessment protocols in clinical settings.

p-Tau217 demonstrates superior diagnostic accuracy among fluid biomarkers for detecting amyloid beta pathology, offering a noninvasive approach to early Alzheimer’s detection.